Manning Meredith, Chief Commercial Officer at Soleno Therapeutics Inc. ($SLNO), sold about $3.04 million in company shares through nine open market transactions over the past year. The most recent sale occurred on March 27, 2025. These sales rank 2,693rd among 11,678 individual insiders in our database, where the average is $8.6 million across about 6.4 transactions per insider. Meredith made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 27, 2026 | SOLENO THERAPEUTICS INC | $SLNO | Manning Meredith | Chief Commercial Officer | S | Common Stock | 558 | $31.72 | 64,507.0000 | 54,921,916 | 0.86% | 0.00% |
| March 27, 2026 | SOLENO THERAPEUTICS INC | $SLNO | Manning Meredith | Chief Commercial Officer | S | Common Stock | 2100 | $31.04 | 65,065.0000 | 54,921,916 | 3.13% | 0.00% |
| March 27, 2026 | SOLENO THERAPEUTICS INC | $SLNO | Manning Meredith | Chief Commercial Officer | S | Common Stock | 4864 | $30.04 | 67,165.0000 | 54,921,916 | 6.75% | 0.01% |
| Jan. 21, 2026 | SOLENO THERAPEUTICS INC | $SLNO | Manning Meredith | Chief Commercial Officer | A | Common Stock | 28600 | $0.00 | 72,029.0000 | 54,921,916 | 65.85% | 0.05% |
| Jan. 21, 2026 | SOLENO THERAPEUTICS INC | $SLNO | Manning Meredith | Chief Commercial Officer | A | Employee stock option (right to buy) | 32800 | $0.00 | 32,800.0000 | 54,921,916 | 9999.99% | 0.06% |
| Dec. 15, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Manning Meredith | Chief Commercial Officer | F | Common Stock | 1922 | $49.95 | 43,429.0000 | 54,921,916 | 4.24% | 0.00% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Manning Meredith | Chief Commercial Officer | S | Common Stock | 225 | $71.74 | 45,385.0000 | 40,175,926 | 0.49% | 0.00% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Manning Meredith | Chief Commercial Officer | S | Common Stock | 34 | $72.64 | 45,351.0000 | 40,175,926 | 0.07% | 0.00% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Manning Meredith | Chief Commercial Officer | M | Common Stock | 37000 | $46.31 | 82,351.0000 | 40,175,926 | 81.59% | 0.09% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Manning Meredith | Chief Commercial Officer | S | Common Stock | 37000 | $67.04 | 45,351.0000 | 40,175,926 | 44.93% | 0.09% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Manning Meredith | Chief Commercial Officer | S | Common Stock | 668 | $65.97 | 52,932.0000 | 40,175,926 | 1.25% | 0.00% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Manning Meredith | Chief Commercial Officer | M | Employee stock option (right to buy) | 37000 | $0.00 | 91,000.0000 | 40,175,926 | 28.91% | 0.09% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Manning Meredith | Chief Commercial Officer | S | Common Stock | 1087 | $66.79 | 51,845.0000 | 40,175,926 | 2.05% | 0.00% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Manning Meredith | Chief Commercial Officer | S | Common Stock | 1976 | $67.70 | 49,869.0000 | 40,175,926 | 3.81% | 0.00% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Manning Meredith | Chief Commercial Officer | S | Common Stock | 2599 | $68.79 | 47,270.0000 | 40,175,926 | 5.21% | 0.01% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Manning Meredith | Chief Commercial Officer | S | Common Stock | 1505 | $69.84 | 45,765.0000 | 40,175,926 | 3.18% | 0.00% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Manning Meredith | Chief Commercial Officer | S | Common Stock | 155 | $70.73 | 45,610.0000 | 40,175,926 | 0.34% | 0.00% |
| Jan. 21, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Manning Meredith | Chief Commercial Officer | A | Employee stock option (right to buy) | 29200 | $0.00 | 29,200.0000 | 40,175,926 | 9999.99% | 0.07% |
| Jan. 21, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Manning Meredith | Chief Commercial Officer | A | Common Stock | 13600 | $0.00 | 53,600.0000 | 40,175,926 | 34.00% | 0.03% |
| July 17, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Manning Meredith | Chief Commercial Officer | A | Common Stock | 40000 | $0.00 | 40,000.0000 | 16,492,132 | 9999.99% | 0.24% |